Treatment of female IBS patients with alosetron, a potent and selective 5HT3-receptor antagonist

Mangel, AW., Camilleri, M., Chey, WY., Hamm, LR., Harding, JP., Lawler, C., Dukes, GE., McSorley, D., Kong, S., Heath, AT., & Northcutt, AR. (1999). Treatment of female IBS patients with alosetron, a potent and selective 5HT3-receptor antagonist. Gastroenterology, 116(4), A1036-A1036.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Community overdose surveillance
Article

Tailoring off the shelf global evidence with local implementation research can boost action on overweight and obesity
Article

In-home visits and subsequent health outcomes in Medicare Advantage beneficiaries with coronary artery disease, diabetes, hypertension, and depression